Speakers from Touchstone Exploration, Shanta Gold, Savannah Resources and Kavango Resources feature in our Natural Resources webinar on May 25th. Please register here.

Less Ads, More Data, More Tools Register for FREE

UPDATE 1-Canada has signed deal for AstraZeneca vaccine candidate - PM

Fri, 25th Sep 2020 17:55

(Adds details of announcement, background)

OTTAWA, Sept 25 (Reuters) - Canada has signed a deal with
Cambridge-based AstraZeneca PLC to buy up to 20 million
doses of its COVID-19 vaccine candidate, Prime Minister Justin
Trudeau said on Friday.

Trudeau also told a news conference that Ottawa would invest
C$440 million ($328 million) in the COVID-19 vaccine Global
Access Facility, a global procurement mechanism designed to help
deliver fair, equitable and timely access to vaccines.

Canada has already struck agreements for a total of around
300 million doses of vaccine candidates from Pfizer Inc,
Novavax Inc, Sanofi, GlaxoSmithKline Plc
, Moderna and Johnson & Johnson.

The AstraZeneca medication is among the leading candidates
in the global race for a vaccine, now in late-stage trials in
Britain, South Africa and elsewhere.

Trials were halted in early September after one participant
developed a serious illness. The U.S. trial remains paused, but
others have resumed.
($1=1.3415 Canadian dollars)
(Reporting by David Ljunggren; Editing by Aurora Ellis)

Related Shares

More News

IN BRIEF: EMA starts rolling review of Covid treatment by GSK and Vir

IN BRIEF: EMA starts rolling review of Covid treatment by GSK and Vir

7 May 21 14:08

UK to give under 40s alternative to AstraZeneca vaccine

(Sharecast News) - The UK government decided on Friday to offer people under 40 an alternative to the AstraZeneca Covid-19 vaccine, reported Bloomberg.

7 May 21 09:49

All under-40s to be offered alternative to AstraZeneca vaccine

All under-40s to be offered alternative to AstraZeneca vaccine

7 May 21 08:49

AstraZeneca reports positive results in Phase 3 lung cancer drug trial

AstraZeneca reports positive results in Phase 3 lung cancer drug trial

7 May 21 08:32

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.